Advertisement
Advertisement

AORT

AORT logo

Artivion Inc

30.83
USD
-0.41
-1.31%
Jan 17, 15:58 UTC -5
Closed
...

Artivion Inc Profile

About

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia.

Info & Links

CEO

J. Patrick Mackin

Headquarters

1655 Roberts Boulevard, NW
Kennesaw, GA 30144, UNITED STATES

Auditor

Ernst & Young, LLP

Share holders

175

Employees

1,500

Artivion Inc Statistics

Valuation Measures

Market Capitalization2

1.29B

Enterprise Value

1.55B

Enterprise Value/EBITDA(ttm)

24.62

Price to Earnings Ratio(ttm)

83.00

Price to Sales(ttm)

3.25

Price to Book(mrq)

4.11

Price to Cash(ytd)

38.89

Profitability

Gross Margin(ttm)

64.53%

Operating Margin(ttm)

3.94%

Profit Margin(ttm)

-0.24%

Return on Equity(ttm)

5.15%

Return on Invested Capital(ttm)

-0.23%

Return on Assets(ttm)

1.91%

Income Statement

Revenue(ttm)

384.90M

Revenue Per Share(ttm)

9.18

Gross Profit(ttm)

248.37M

EBITDA(ttm)3

63.10M

Net Income Available to Common(ttm)

-736.00K

Diluted EPS(ttm)

-0.02

Share Statistics

Beta (5Y Monthly)

1.74

52-Week Change

70.33%

S&P 500 52-Week Change

25.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

41.92M

Dividend Yield

0.00%

Float4

38.52M

% Held by Insiders

8.10%

% Held by Institutions

86.37%

Balance Sheet

Total Cash(mrq)

56.17M

Total Cash Per Share(mrq)

1.34

Total Debt(mrq)

317.16M

Total Debt/Equity(mrq)

104.08%

Current Ratio(mrq)

1.88%

Quick Ratio(mrq)

1.33%

Book Value Per Share(mrq)

7.27

Cash Flow

Operating Cash Flow Per Share(ytd)

0.29

Free Cash Flow(ytd)

2.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement